Full Text View
Tabular View
Study Results
Related Studies
Safety and Efficacy of Mipomersen (ISIS 301012) As Add-on Therapy in High Risk Hypercholesterolemic Patients
This study has been completed.
Study NCT00770146   Information provided by Genzyme, a Sanofi Company

First Received on October 8, 2008.   Last Updated on February 15, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional conditions recognized in this trial
More general conditions related to this trial
Interventions listed in this trial
Sponsors listed in this trial